Vincristine

- TRADE NAME: Vincasar (Teva)
- INDICATIONS: Leukemias, lymphomas, neuroblastoma, Wilm's tumor
- SYNONYM: oncovin
- CLASS: Antimitotic, Vinca alkaloid
- HALF-LIFE: 24 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Aldesleukin, Aprepitant, Bromelain, Fluconazole, Gadobenate, Influenza Vaccine, Itraconazole, Ketoconazole, Lopinavir, Miconazole, Nifedipine, Posaconazole, Thalidomide
PREGNANCY CATEGORY: D
Please login to see the rest of this drug profile
SKIN.
HAIR.
NAILS.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
HEMATOLOGIC.
LOCAL.
NEUROMUSCULAR/SKELETAL.
OCULAR.
OTIC.
RENAL.
RESPIRATORY.
OTHER.
Page last updated 01/06/2023
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations 
- Breast feeding
- Geriatric
- Pediatric